Untitled 1

Do you have a patient suffering from medication side effects? Do you have patients that are ready to get off their medications? A step-by-step method is now available. Insomnia, anxiety, head symptoms are the common withdrawal side effects from psychoactive drugs which stops most people from being able to completely get off their medication. Those symptoms no longer need to get in the way of a successful taper.

Deciding how fast to titrate off a medication can be a confusing decision. Which medication to taper first needs to based on drug/drug interactions associated with the CYP enzymes. Did you know, if you taper a patient off the antidepressant first, while they concurrently take a benzodiazepine, the patient will go into withdrawal on the benzodiazepine as well? Click here for the method used by physicians worldwide to taper patients off psychoactive medications.

Review by Dr. Hyla Cass M.D. Psychiatrist "Here is an essential handbook on how to safely and more easily wean yourself (under medical supervision) off the heavily over-prescribed psychotropic medications. I have used the program with my patients and it works!” Hyla Cass M.D. Author of Supplement Your Prescription

Internal Web Site Links
Antidepressants:
Adapin Amitriptyline Amoxapine Anafranil Celexa Cymbalta Desipramine Effexor Imipramine Lexapro Luvox Paxil Prozac Sarafem Trazodone Wellbutrin Zoloft

Benzodiazepines: Ambien Ativan Klonopin Librium Valium Xanax

Other Medications: Abilify Adderall Depakote Haldol Ritalin Seroquel Strattera Zyprexa

Other Links: Glutathione Weight Loss Lose the antidepressant induced weight gain

Untitled 1

FOR IMMEDIATE RELEASE

11 August 2002

FOR MORE INFORMATION:

Marla Filidei (800)-869-2247
CCHR International

CHILD PSYCHIATRY PUT ON NOTICE

DUTCH COMMISSION FINDS PSYCHIATRIC CLAIM IS FALSE

- ADHD IS NOT A BRAIN DISORDER –

The Netherlands Advertisement Code Commission (Reclame Code Commissie) has ruled that the country’s Brain Foundation cannot claim that the controversial psychiatric condition Attention Deficit Hyperactivity Disorder (ADHD) is a neurobiological disease or brain dysfunction. The Commission ordered the Foundation to cease such false claims in their advertising.

The Advertisement Code Commission was responding to a complaint brought by the Dutch chapter of the Citizens Commission on Human Rights (CCHR), an international psychiatric watchdog organization established by the Church of Scientology.

In its decision handed down on August 6^th, the Advertisement Code Commission found that the Brain Foundation had falsely advertised and solicited funding by publishing ads in newspapers, magazines, flyers and on TV that stated ADHD is an “inherent brain dysfunction.”

The Advertisement Code Commission decision stated, “The information that the defendant presented gives no grounds for the definitive statement that ADHD is an inherent brain dysfunction…. Under the circumstances, the defendant has not been careful enough and the advertisement is misleading.”

The decision has prompted calls for similar orders to be made in the U.S. in the wake of a 1,100% increase in ADHD being diagnosed in American children between 1987 and 2001.

CCHR’s international headquarters in Los Angeles says that similar false claims have been made about ADHD in the U.S. despite a 1999 Surgeon General report stating otherwise. The report on mental health, specifically stated that, “No single gene has been found to be responsible for any specific mental disorder” Also, the report states “There is no definite lesion, laboratory test or abnormality in brain tissue that can identify the [mental] illness.”

Ms. Jan Eastgate, President of CCHR International, stated, “Fraudulent claims that ADHD is neurobiological must stop. We have already filed a similar complaint in the United States. Psychiatrists cannot be allowed to mislead parents, and children need to be protected from false labels and harmful psychiatric drugs. Child Psychiatrists are put on notice that we will continue to file complaints and/or bring legal action as necessary against false and misleading claims.”